Rise of AI continues to re-write life sciences IP strategies in 2022
A spate of pharma-high tech innovation partnerships have dominated opening days of the year
A spate of pharma-high tech innovation partnerships have dominated opening days of the year
Lighting firm Signify and panel-maker Samsung Display each acquired portfolios from one of Japan’s leading IP dealmakers last month
Saturday Opinion: Technology solutions that have helped the world through the pandemic would look very different absent a sophisticated IP licensing ecosystem, argues Dolby GC Andy Sherman
Globalisation in the 5G era has reduced the clout of portfolios centred on the country, but decisions taken by the government, the courts and in boardrooms have hastened the process
17 June 2021
Recent recordals show the electric car maker has cut a deal with Panasonic, assimilated a large portfolio of solar rights and gained assets via M&A deals
16 June 2021
If licensors are unwilling to be reasonable, then this is an issue that will have to be sorted out by the courts, says Paul Lin in an exclusive interview
15 June 2021
Latest Royalty Pharma investment shows is further evidence of the increasing IP monetisation options open to healthcare innovators
15 June 2021
New lawsuit puts the structure of Atlantic IP Services, the prolific Irish patent licensing firm, under the spotlight
15 June 2021
Partnership agreements are a growing part of the biopharma R&D process, so anticipating potential pitfalls in such arrangements is vital
14 June 2021
IP Bridge lawsuits against Nokia and Ericsson confirm NPE’s focus on the wireless space
14 June 2021
The pharmaceutical sector has always been hot on dealmaking and the most active players continue to make serious portfolio gains in terms of volume and quality
11 June 2021
The IPO takes issue with rules proposed by the Chinese patent office to filter out 'abnormal' applications
10 June 2021
That both the Xperi subsidiary and the defensive aggregator were involved in bidding for MobiTV’s assets shows the growing importance of the content delivery space to dealmakers
04 June 2021
Get unlimited access to all IAM content